Ocuflox and Punctate keratitis - a phase IV clinical study of FDA data

Summary:

Punctate keratitis is reported as a side effect among people who take Ocuflox (ofloxacin), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Betadine, and have Diabetic retinal oedema.

The phase IV clinical study analyzes which people have Punctate keratitis when taking Ocuflox. It is created by eHealthMe based on reports of 489 people who have side effects when taking Ocuflox from the FDA, and is updated regularly.

What is Ocuflox?

Ocuflox has active ingredients of ofloxacin. eHealthMe is studying from 492 Ocuflox users. Check the latest studies of Ocuflox.

What is Punctate keratitis?

Punctate keratitis (inflammation of the cornea with tiny spots) is found to be associated with 96 drugs and 225 conditions by eHealthMe. Check the latest studies of Punctate keratitis.

On Jul, 13, 2026

489 people reported to have side effects when taking Ocuflox.
Among them, 16 people (3.27%) have Punctate keratitis.

Among these 16 people:

How long have people been on Ocuflox when they have Punctate keratitis? *

What is the gender of people who have Punctate keratitis when taking Ocuflox? *

female: 81.25 %
male: 18.75 %

What is the age of people who have Punctate keratitis when taking Ocuflox? *

What are other drugs people take besides Ocuflox? *

What are other side effects people have besides Punctate keratitis? *

Ocular Hyperaemia (an abnormally large amount of blood in eye): 15 people, 93.75%
Corneal Epithelium Defect (outer layer defect of cornea): 15 people, 93.75%
Visual Acuity Reduced (reduced clearness of vision): 14 people, 87.50%
Corneal Oedema (corneal swelling): 14 people, 87.50%
Vision Blurred: 13 people, 81.25%
Eye Irritation: 10 people, 62.50%
Eye Pain: 9 people, 56.25%
Foreign Body Sensation In Eyes (feeling of something in eye): 8 people, 50.00%
Corneal Abrasion (loss of the surface of cornea): 7 people, 43.75%
Photophobia (extreme sensitivity to light): 5 people, 31.25%

What are the existing conditions these people have? *

Macular Oedema (fluid and protein deposits collect on or under the macula of the eye (a yellow central area of the retina) and causes it to thicken): 1 person, 6.25%
Diabetic Retinopathy (damage to the retina caused by complications of diabetes): 1 person, 6.25%
Diabetic Retinal Oedema (excessive build-up of fluid in the retina due to diabetes): 1 person, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Ocuflox and have Punctate keratitis?

- Check whether Punctate keratitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Ocuflox:

Ocuflox (492 reports)

Browse all side effects of Ocuflox:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Punctate keratitis:

Punctate keratitis (96 drugs)

Browse all the conditions that are associated with Punctate keratitis:

Punctate keratitis (225 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on ofloxacin (the active ingredients of Ocuflox) and Ocuflox (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.